| 000 | 01486 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513100038.0 | ||
| 264 | 0 | _c19961203 | |
| 008 | 199612s 0 0 eng d | ||
| 022 | _a0022-510X | ||
| 024 | 7 |
_a10.1016/0022-510x(95)00352-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJiang, N | |
| 245 | 0 | 0 |
_aAdministration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat. _h[electronic resource] |
| 260 |
_bJournal of the neurological sciences _cJun 1996 |
||
| 300 |
_a36-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArterial Occlusive Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 | _aCerebral Arteries |
| 650 | 0 | 4 |
_aCerebral Infarction _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aValine _xanalogs & derivatives |
| 700 | 1 | _aZhang, R L | |
| 700 | 1 | _aBaron, B M | |
| 700 | 1 | _aChopp, M | |
| 773 | 0 |
_tJournal of the neurological sciences _gvol. 138 _gno. 1-2 _gp. 36-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0022-510x(95)00352-3 _zAvailable from publisher's website |
| 999 |
_c8787790 _d8787790 |
||